Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041326
Filing Date
2019-11-07
Accepted
2019-11-07 06:31:56
Documents
68
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20190930.htm 10-Q 2226711
2 EX-10.1 krtx-ex101_77.htm EX-10.1 78269
3 EX-31.1 krtx-ex311_8.htm EX-31.1 9453
4 EX-31.2 krtx-ex312_6.htm EX-31.2 9434
5 EX-32.1 krtx-ex321_7.htm EX-32.1 8249
  Complete submission text file 0001564590-19-041326.txt   7367662

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT krtx-20190930.xml EX-101.INS 1428538
7 XBRL TAXONOMY EXTENSION SCHEMA krtx-20190930.xsd EX-101.SCH 51930
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20190930_cal.xml EX-101.CAL 48303
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20190930_def.xml EX-101.DEF 218421
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20190930_lab.xml EX-101.LAB 424854
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20190930_pre.xml EX-101.PRE 343915
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 191198016
SIC: 2834 Pharmaceutical Preparations